Search for a research project

Search for a research project

Other search option(s)

89 Result(s)

Research projects

A preclinical study to treat neuromuscular diseases caused by mutations in the small heat shock protein HSPB8 University of Antwerp - UA Peripheral Neuropathy Research Group

Emerging team in rare diseases: achieving the "triple aim" for inborn errors of metabolism Children's Hospital of Eastern Ontario Newborn Screening Ontario

Emerging team in rare diseases: achieving the "triple aim" for inborn errors of metabolism University of Ottawa Department of Epidemiology and Community Medicine

The role of polyamine metabolism and NAD+-dependent enzymes, sirtuins and poly(ADP-ribose) polymerases, in diseases characterized with mitochondrial dysfunction. University of Helsinki Stem Cells and Metabolism Research Program

Mechanisms by which alternative oxidase ameliorates locomotor deficit due to cytochrome c oxidase deficiency in Drosophila University of Helsinki Stem Cells and Metabolism Research Program

Mitochondrial dysfunction remodels vitamin-B metabolism: Roles for neurological disease and therapy University of Helsinki Stem Cells and Metabolism Research Program

Tissue-specific mitochondrial signaling and adaptations to mistranslation University of Helsinki Stem Cells and Metabolism Research Program

Molecular Thermobiology of Mitochondria Tampere University Faculty of Medicine and Health Technology

Prion protein dysfunction in inherited metabolic myopathies Institution: Information not provided - FR

In vivo investigation of skeletal muscle function after chronic administration of CsA in a mouse model of MItochondrial MYopathy: a combined anatomical, metabolic and functional study using MRI and 31P-MRS Institution: Information not provided - FR

Abnormal mitoribosomal biogenesis and protein maturation in human mitochondrial diseases. Institution: Information not provided - FR

CREB Binding Protein (CBP) co-activator: a new player for mitochondrial (dys)function in myogenesis? Institution: Information not provided - FR

Influence of mtDNA background (haplogroups) on mitochondrial pathologies. Institution: Information not provided - FR

Does nuclear transfer alter mitochondrial-nuclear cross-talks in the human preimplantation embryo? Institution: Information not provided - FR

Impact of pre-phonation inspiratory volume on speech quality of neuromuscular patients requiring non invasive ventilation Institution: Information not provided - FR

Impact of the type of interface in neuromuscular patients treated with nocturnal Noninvasive Ventilation: a randomized crossover trial Institution: Information not provided - FR

Mitochondrial myopathies with mtDNA instability: the role of cristae maintenance Institution: Information not provided - FR

Impact of blowpipe training on cough efficiency in neuromuscular patients : a prospective evaluation. Institution: Information not provided - FR

ID2STOP Orphan : InDividualized Drug Selection Technology for Orphan Patients Faculté des Sciences Pharmaceutiques et Biologiques de Lille APTEEUS: le patient au coeur de la découverte de son traitement

Muscle stem cell quiescence and heterogeneity Faculté de Médecine de Créteil Equipe "Biologie du système neuromusculaire"

NMD-CHIP: design, production and technical validation of candidate genes targeted chips (WP3) Généthon Centre de Recherche Généthon

GENOMIT : Mitochondrial Disorders: from a genome-wide Registry to medical genomics, toward molecular mechanisms and new therapies - FR CHU Paris - Hôpital Robert Debré Equipe "Physiopathologie et thérapie des maladies mitochondriales"

Research on the differential effect of Pioglitazone in mitochondrial diseases CHU Paris - Hôpital Robert Debré Equipe "Physiopathologie et thérapie des maladies mitochondriales"

GENOMIT : Mitochondrial Disorders: from a genome-wide Registry to medical genomics, toward molecular mechanisms and new therapies - FR IMAGINE - Institut des Maladies Génétiques Equipe "Génétique des maladies mitochondriales"

Identification of nuclear genes of mitochondrial diseases with neurological involvement Laboratoire de Génétique des maladies mitochondriales UMR_S1163 : Génétique des maladies mitochondriales

STaHR : Stimulation of Targeted Homologous Recombination for Gene Therapy - FR Muséum National d'Histoire Naturelle Laboratoire Structure et Instabilité des Génomes - INSERM U1154 - CNRS 7196

HUMAn Neuromuscular Integrative System for drug discovery Université Paris Descartes - Paris 5 Centre de Neurophysique, Physiologie et Pathologie - CNRS UMR 8119

Ubinergy: Control of mitochondrial energy metabolism by the ubiquitin/proteasome system CHU de Bordeaux-GH Pellegrin Laboratoire Maladies Rares : Génétique et Métabolisme (MRGM)

FROGH : FRench Regional Origins in Genetics for Health - FR Institut de Recherche en Santé - Université de Nantes L'Institut du thorax - Inserm UMR 1087 / CNRS UMR 6291

Identification of new genes and possible de novo mutations in early-onset mitochondrial disorders Faculté de médecine de Nice Sophia-Antipolis IRCAN - Institut de Recherche sur le Cancer et le Vieillissement (INSERM U 1081 - CNRS UMR7284)

GENOMIT- Mitochondrial Disorders: from a pan-European Registry to medical genetics, toward molecular mechanisms and new therapeutic options - DE (partner no 1) LMU Klinikum der Universität München - Campus Großhadern Arbeitsgruppe Neurogenetik

Clinical and genetic presentation of juvenile mitochondriopathies Universitätsmedizin Göttingen Klinik für Kinder- und Jugendmedizin

Investigation of mitochondrial dysfunction with genomic and biochemical analysis Institute of Genomic Medicine and Rare Disorders, Semmelweis University Genetics Laboratory

Telethon Undiagnosed Disease Program - Revised Proposal TIGEM - Telethon Institute of Genetics and Medicine Genomic Medicine - Telethon Institute of Genetics and Medicine

New technologies and new strategies for neonatal screening IRCCS Istituto G. Gaslini - Ospedale Pediatrico Laboratorio per lo Studio degli Errori Congeniti del Metabolismo

Identification and characterization of nuclear genes responsible for human mitochondrial disorders Fondazione IRCCS Istituto Neurologico "C. Besta" - sede Bicocca U.O. di Neurogenetica Molecolare

MitMed consortium: from the identification and characterization of nuclear genes responsible for human mitochondrial disorders towards potential therapeutic approaches in experimental models Fondazione IRCCS Istituto Neurologico "C. Besta" - sede Bicocca U.O. di Neurogenetica Molecolare

NEUROMICS: Integrated European Project on Omics Research of Rare Neuromuscular and Neurodegenerative Diseases - IT Università degli Studi di Milano - Scienze Farmacologiche e Biomolecolari Laboratorio di Biologia delle Cellule Staminali

Developing tools for trial readiness in primary mitochondrial myopathies of the adulthood Azienda Ospedaliero Universitaria Pisana - Ospedale S. Chiara U.O. di Neurologia - Neurofisiopatologia

The role of Raptor/mTORC1 in adult skeletal muscle Venetian Institute of Molecular Medicine Dipartimento di Scienze Biomediche

MitCare-2 Venetian Institute of Molecular Medicine Dulbecco Telethon Institute

Management ofthe clinical diagnostic centre for rare intractable diseases with genome instability and development of potential therapeutic medicine Research Institute of Environmental Medicine, Nagoya University

Establishment of the Next-generation Muti-omics Clinical Diagnostic Centre for rare intractable diseases with genome instability Research Institute of Environmental Medicine, Nagoya University

The creation of evidence which lead to medical practice with a view to revision of manuals/guideline of mitochondrial disease Chiba Cancer Center Research Institute

Formation of integrated omics analysis base of refractory diseases in children and perinatal period National Center for Child Health and Development Research Institute

Establishment of Integrated Genome Analysis Center for Hereditary Muscle Disease National Center of Neurology and Psychiatry Department of Neuromuscular Research

Creation of a database of genetic variants in the gypsy population for the diagnosis and prevention of neuromuscular diseases IBIS - Instituto de Biomedicina de Sevilla Grupo de Fisiología molecular de la sinapsis

Testing the effectiveness the of Nanostring nCounter platform detecting defects of gene expression in patients with undiagnosed rare diseases Complejo Hospitalario Universitario de Santiago Unidad de Diagnóstico y Tratamiento de Enfermedades Metabólicas

RAREGenomics: Network of Genomic, Functional, Clinical and Therapeutic Resources for the Study of Rare Neurological Diseases Hospital Universitario Fundación Jiménez Díaz Servicio de Genética Clínica

Development of experimental models for the study, diagnosis and therapy of mitochondrial diseases Universidad Autónoma de Madrid. Facultad de Medicina Departamento de Bioquímica

Inborn errors of endocrinology and metabolism Karolinska Institutet - Solna Department of Molecular Medicine and Surgery

Clinical Characteristics of Adult Patients With Inborn Errors of Metabolism in French-speaking Switzerland Centre Hospitalier Universitaire Vaudois CHUV - Hôpital Beaumont - CMM - Centre des Maladies Moléculaires

Clinical development of erythrocyte encapsulated thymidine phosphorylase- a therapy for mitochondrial neurogastrointestinal encephalomyopathy The Aplastic Anaemia Trust The Purine Metabolic Patients' Association

MICA: Clinical development of erythrocyte encapsulated thymidine phosphorylase - a therapy for mitochondrial neurogastrointestinal encephalomyopathy St George's University of London Molecular and Clinical Sciences Reseach Institute

Understanding the mechanism underpinning segregation of mitochondrial DNA mutation during somatic cell reprogramming Institution: Information not provided - UK

MICA: Randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in patients with Mitochondrial Myopathy (AIMM) Newcastle University Institute for Ageing (NUIA), Newcastle Biomedicine Wellcome Trust Centre for Mitochondrial Research (Institute of Neuroscience)

TREAT-NMD: Accelerating Treatments for Neuromuscular Diseases (coordination) Newcastle upon Tyne Hospitals NHS Trust John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

Basic and clinical studies in immune function and metabolism Institution: Information not provided - US

Metabolic engineering in humans: altered gut microbes as a therapeutic platform Institution: Information not provided - US

Multicentric Research projects

Maternal Infant Child and Youth Research Network (MICYRN) University of British Columbia Maternal Infant Child and Youth Research Network

CIMDRN- Canadian Inherited Metabolic Diseases Research Network University of Ottawa Faculty of Medicine -

NMD-CHIP: Development of targeted DNA-Chips for High Throughput Diagnosis of NeuroMuscular Disorders Institution: Information not provided - FR

MYORES: European Muscle Development Network (FINISHED) Faculté de médecine de Clermont-Ferrand Laboratoire de Génétique, Reproduction et Développement

STaHR : Stimulation of Targeted Homologous Recombination for Gene Therapy Muséum National d'Histoire Naturelle Laboratoire Structure et Instabilité des Génomes - INSERM U1154 - CNRS 7196

MeetOChondrie: research group on mitochondria and related disorders Université Bordeaux 2 - Victor Ségalen Physiopathologie mitochondriale

Réseau Sud-Ouest des erreurs innées du métabolisme Institut Fédératif de Biologie Laboratoire de biochimie

French network on mitochondrial diseases CHU d'Angers UF de Biologie Moléculaire

FROGH : FRench Regional Origins in Genetics for Health Institut de Recherche en Santé - Université de Nantes L'Institut du thorax - Inserm UMR 1087 / CNRS UMR 6291

NMD-CHIP: development of targeted DNA-chips for high throughput diagnosis of neuromuscular disorders CHU de Marseille - Hôpital de la Timone Laboratoire de génétique moléculaire

Neuromics: Integrated European -omics research project for diagnosis and therapy in rare neuromuscular and neurodegenerative diseases Institut für Medizinische Genetik und angewandte Genomik Tübingen Institut für Medizinische Genetik und angewandte Genomik

mitoNET: german Network for mitochondrial diseases Deutsches MITONET e.V. c/o Dr. Bert Obermaier-Kusser Deutsches MITONET e.V.

GENOMIT: Mitochondrial disorders - Connecting Biobanks, Empowering Genetic Diagnostics and Exploring Disease Models Institut für Humangenetik der TU München Institut für Humangenetik

GENOMIT: Mitochondrial Disorders: from a genome-wide Registry to medical genomics, toward molecular mechanisms and new therapies Institut für Humangenetik der TU München Institut für Humangenetik

GENOMIT- Mitochondrial Disorders: from a pan-European Registry to medical genetics, toward molecular mechanisms and new therapeutic options Institut für Humangenetik der TU München Institut für Humangenetik

mitoNET: german Network for mitochondrial diseases LMU Klinikum der Universität München - Campus Großhadern Arbeitsgruppe Neurogenetik

A preclinical study to treat neuromuscular diseases caused by mutations in the small heat shock protein HSPB8
University of Antwerp - UA

Peripheral Neuropathy Research Group

Emerging team in rare diseases: achieving the "triple aim" for inborn errors of metabolism
Children's Hospital of Eastern Ontario

Newborn Screening Ontario

Emerging team in rare diseases: achieving the "triple aim" for inborn errors of metabolism
University of Ottawa

Department of Epidemiology and Community Medicine

The role of polyamine metabolism and NAD+-dependent enzymes, sirtuins and poly(ADP-ribose) polymerases, in diseases characterized with mitochondrial dysfunction.
University of Helsinki

Stem Cells and Metabolism Research Program

Mechanisms by which alternative oxidase ameliorates locomotor deficit due to cytochrome c oxidase deficiency in Drosophila
University of Helsinki

Stem Cells and Metabolism Research Program

Mitochondrial dysfunction remodels vitamin-B metabolism: Roles for neurological disease and therapy
University of Helsinki

Stem Cells and Metabolism Research Program

Tissue-specific mitochondrial signaling and adaptations to mistranslation
University of Helsinki

Stem Cells and Metabolism Research Program

Molecular Thermobiology of Mitochondria
Tampere University

Faculty of Medicine and Health Technology

Prion protein dysfunction in inherited metabolic myopathies
Institution: Information not provided - FR

In vivo investigation of skeletal muscle function after chronic administration of CsA in a mouse model of MItochondrial MYopathy: a combined anatomical, metabolic and functional study using MRI and 31P-MRS
Institution: Information not provided - FR

Abnormal mitoribosomal biogenesis and protein maturation in human mitochondrial diseases.
Institution: Information not provided - FR

CREB Binding Protein (CBP) co-activator: a new player for mitochondrial (dys)function in myogenesis?
Institution: Information not provided - FR

Influence of mtDNA background (haplogroups) on mitochondrial pathologies.
Institution: Information not provided - FR

Does nuclear transfer alter mitochondrial-nuclear cross-talks in the human preimplantation embryo?
Institution: Information not provided - FR

Impact of pre-phonation inspiratory volume on speech quality of neuromuscular patients requiring non invasive ventilation
Institution: Information not provided - FR

Impact of the type of interface in neuromuscular patients treated with nocturnal Noninvasive Ventilation: a randomized crossover trial
Institution: Information not provided - FR

Mitochondrial myopathies with mtDNA instability: the role of cristae maintenance
Institution: Information not provided - FR

Impact of blowpipe training on cough efficiency in neuromuscular patients : a prospective evaluation.
Institution: Information not provided - FR

ID2STOP Orphan : InDividualized Drug Selection Technology for Orphan Patients
Faculté des Sciences Pharmaceutiques et Biologiques de Lille

APTEEUS: le patient au coeur de la découverte de son traitement

Muscle stem cell quiescence and heterogeneity
Faculté de Médecine de Créteil

Equipe "Biologie du système neuromusculaire"

NMD-CHIP: design, production and technical validation of candidate genes targeted chips (WP3)
Généthon

Centre de Recherche Généthon

GENOMIT : Mitochondrial Disorders: from a genome-wide Registry to medical genomics, toward molecular mechanisms and new therapies - FR
CHU Paris - Hôpital Robert Debré

Equipe "Physiopathologie et thérapie des maladies mitochondriales"

Research on the differential effect of Pioglitazone in mitochondrial diseases
CHU Paris - Hôpital Robert Debré

Equipe "Physiopathologie et thérapie des maladies mitochondriales"

GENOMIT : Mitochondrial Disorders: from a genome-wide Registry to medical genomics, toward molecular mechanisms and new therapies - FR
IMAGINE - Institut des Maladies Génétiques

Equipe "Génétique des maladies mitochondriales"

Identification of nuclear genes of mitochondrial diseases with neurological involvement
Laboratoire de Génétique des maladies mitochondriales

UMR_S1163 : Génétique des maladies mitochondriales

STaHR : Stimulation of Targeted Homologous Recombination for Gene Therapy - FR
Muséum National d'Histoire Naturelle

Laboratoire Structure et Instabilité des Génomes - INSERM U1154 - CNRS 7196

HUMAn Neuromuscular Integrative System for drug discovery
Université Paris Descartes - Paris 5

Centre de Neurophysique, Physiologie et Pathologie - CNRS UMR 8119

Ubinergy: Control of mitochondrial energy metabolism by the ubiquitin/proteasome system
CHU de Bordeaux-GH Pellegrin

Laboratoire Maladies Rares : Génétique et Métabolisme (MRGM)

FROGH : FRench Regional Origins in Genetics for Health - FR
Institut de Recherche en Santé - Université de Nantes

L'Institut du thorax - Inserm UMR 1087 / CNRS UMR 6291

Identification of new genes and possible de novo mutations in early-onset mitochondrial disorders
Faculté de médecine de Nice Sophia-Antipolis

IRCAN - Institut de Recherche sur le Cancer et le Vieillissement (INSERM U 1081 - CNRS UMR7284)

GENOMIT- Mitochondrial Disorders: from a pan-European Registry to medical genetics, toward molecular mechanisms and new therapeutic options - DE (partner no 1)
LMU Klinikum der Universität München - Campus Großhadern

Arbeitsgruppe Neurogenetik

Clinical and genetic presentation of juvenile mitochondriopathies
Universitätsmedizin Göttingen

Klinik für Kinder- und Jugendmedizin

Investigation of mitochondrial dysfunction with genomic and biochemical analysis
Institute of Genomic Medicine and Rare Disorders, Semmelweis University

Genetics Laboratory

Telethon Undiagnosed Disease Program - Revised Proposal
TIGEM - Telethon Institute of Genetics and Medicine

Genomic Medicine - Telethon Institute of Genetics and Medicine

New technologies and new strategies for neonatal screening
IRCCS Istituto G. Gaslini - Ospedale Pediatrico

Laboratorio per lo Studio degli Errori Congeniti del Metabolismo

Identification and characterization of nuclear genes responsible for human mitochondrial disorders
Fondazione IRCCS Istituto Neurologico "C. Besta" - sede Bicocca

U.O. di Neurogenetica Molecolare

MitMed consortium: from the identification and characterization of nuclear genes responsible for human mitochondrial disorders towards potential therapeutic approaches in experimental models
Fondazione IRCCS Istituto Neurologico "C. Besta" - sede Bicocca

U.O. di Neurogenetica Molecolare

NEUROMICS: Integrated European Project on Omics Research of Rare Neuromuscular and Neurodegenerative Diseases - IT
Università degli Studi di Milano - Scienze Farmacologiche e Biomolecolari

Laboratorio di Biologia delle Cellule Staminali

Developing tools for trial readiness in primary mitochondrial myopathies of the adulthood
Azienda Ospedaliero Universitaria Pisana - Ospedale S. Chiara

U.O. di Neurologia - Neurofisiopatologia

The role of Raptor/mTORC1 in adult skeletal muscle
Venetian Institute of Molecular Medicine

Dipartimento di Scienze Biomediche

MitCare-2
Venetian Institute of Molecular Medicine

Dulbecco Telethon Institute

Management ofthe clinical diagnostic centre for rare intractable diseases with genome instability and development of potential therapeutic medicine
Research Institute of Environmental Medicine, Nagoya University

Establishment of the Next-generation Muti-omics Clinical Diagnostic Centre for rare intractable diseases with genome instability
Research Institute of Environmental Medicine, Nagoya University

The creation of evidence which lead to medical practice with a view to revision of manuals/guideline of mitochondrial disease
Chiba Cancer Center Research Institute

Formation of integrated omics analysis base of refractory diseases in children and perinatal period
National Center for Child Health and Development

Research Institute

Establishment of Integrated Genome Analysis Center for Hereditary Muscle Disease
National Center of Neurology and Psychiatry

Department of Neuromuscular Research

Creation of a database of genetic variants in the gypsy population for the diagnosis and prevention of neuromuscular diseases
IBIS - Instituto de Biomedicina de Sevilla

Grupo de Fisiología molecular de la sinapsis

Testing the effectiveness the of Nanostring nCounter platform detecting defects of gene expression in patients with undiagnosed rare diseases
Complejo Hospitalario Universitario de Santiago

Unidad de Diagnóstico y Tratamiento de Enfermedades Metabólicas

RAREGenomics: Network of Genomic, Functional, Clinical and Therapeutic Resources for the Study of Rare Neurological Diseases
Hospital Universitario Fundación Jiménez Díaz

Servicio de Genética Clínica

Development of experimental models for the study, diagnosis and therapy of mitochondrial diseases
Universidad Autónoma de Madrid. Facultad de Medicina

Departamento de Bioquímica

Inborn errors of endocrinology and metabolism
Karolinska Institutet - Solna

Department of Molecular Medicine and Surgery

Clinical Characteristics of Adult Patients With Inborn Errors of Metabolism in French-speaking Switzerland
Centre Hospitalier Universitaire Vaudois CHUV - Hôpital Beaumont -

CMM - Centre des Maladies Moléculaires

Clinical development of erythrocyte encapsulated thymidine phosphorylase- a therapy for mitochondrial neurogastrointestinal encephalomyopathy
The Aplastic Anaemia Trust

The Purine Metabolic Patients' Association

MICA: Clinical development of erythrocyte encapsulated thymidine phosphorylase - a therapy for mitochondrial neurogastrointestinal encephalomyopathy
St George's University of London

Molecular and Clinical Sciences Reseach Institute

Understanding the mechanism underpinning segregation of mitochondrial DNA mutation during somatic cell reprogramming
Institution: Information not provided - UK

TREAT-NMD: Accelerating Treatments for Neuromuscular Diseases (coordination)
Newcastle upon Tyne Hospitals NHS Trust

John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

Basic and clinical studies in immune function and metabolism
Institution: Information not provided - US

Metabolic engineering in humans: altered gut microbes as a therapeutic platform
Institution: Information not provided - US

Maternal Infant Child and Youth Research Network (MICYRN)

University of British Columbia

Maternal Infant Child and Youth Research Network

CIMDRN- Canadian Inherited Metabolic Diseases Research Network

University of Ottawa

Faculty of Medicine -

NMD-CHIP: Development of targeted DNA-Chips for High Throughput Diagnosis of NeuroMuscular Disorders

Institution: Information not provided - FR

MYORES: European Muscle Development Network (FINISHED)

Faculté de médecine de Clermont-Ferrand

Laboratoire de Génétique, Reproduction et Développement

STaHR : Stimulation of Targeted Homologous Recombination for Gene Therapy

Muséum National d'Histoire Naturelle

Laboratoire Structure et Instabilité des Génomes - INSERM U1154 - CNRS 7196

MeetOChondrie: research group on mitochondria and related disorders

Université Bordeaux 2 - Victor Ségalen

Physiopathologie mitochondriale

Réseau Sud-Ouest des erreurs innées du métabolisme

Institut Fédératif de Biologie

Laboratoire de biochimie

French network on mitochondrial diseases

CHU d'Angers

UF de Biologie Moléculaire

FROGH : FRench Regional Origins in Genetics for Health

Institut de Recherche en Santé - Université de Nantes

L'Institut du thorax - Inserm UMR 1087 / CNRS UMR 6291

NMD-CHIP: development of targeted DNA-chips for high throughput diagnosis of neuromuscular disorders

CHU de Marseille - Hôpital de la Timone

Laboratoire de génétique moléculaire

Neuromics: Integrated European -omics research project for diagnosis and therapy in rare neuromuscular and neurodegenerative diseases

Institut für Medizinische Genetik und angewandte Genomik Tübingen

Institut für Medizinische Genetik und angewandte Genomik

mitoNET: german Network for mitochondrial diseases

Deutsches MITONET e.V. c/o Dr. Bert Obermaier-Kusser

Deutsches MITONET e.V.

GENOMIT: Mitochondrial disorders - Connecting Biobanks, Empowering Genetic Diagnostics and Exploring Disease Models

Institut für Humangenetik der TU München

Institut für Humangenetik

GENOMIT: Mitochondrial Disorders: from a genome-wide Registry to medical genomics, toward molecular mechanisms and new therapies

Institut für Humangenetik der TU München

Institut für Humangenetik

GENOMIT- Mitochondrial Disorders: from a pan-European Registry to medical genetics, toward molecular mechanisms and new therapeutic options

Institut für Humangenetik der TU München

Institut für Humangenetik

mitoNET: german Network for mitochondrial diseases

LMU Klinikum der Universität München - Campus Großhadern

Arbeitsgruppe Neurogenetik

BNE: BrainNet Europe II: European brain tissue bank

Zentrum für Neuropathologie und Prionforschung (ZNP)

Zentrum für Neuropathologie und Prionforschung der LMU München

EUROMUSCLENET: Europäisches Informations-Netzwerk über muskuläre Erkrankungen

Charité / Max-Delbrück-Centrum für Molekulare Medizin

Muskelforschung mit Hochschulambulanz für Muskelkrankheiten

UnRareNet: a muticenter collaborative research network for the identification and study of rare undiagnosed patients (completed)

IRCCS Ospedale Pediatrico Bambino Gesù - SEDE GIANICOLO

Servizio Clinico di Consulenza Genetica

EUMITOCOMBAT: rational treatment strategies combating mitochondrial oxidative phosphorylation (OXPHOS) disorders (TERMINATED)

Radboudumc - Radboud universitair medisch centrum

Radboud Centrum voor Mitochondriële Geneeskunde

MITOCIRCLE: mitochondrial diseases: from bedside to genome to bedside (FINISHED)

AZM - Academisch Ziekenhuis Maastricht

Laboratorium Clinical Genomics

ENMC: European NeuroMuscular Centre

European NeuroMuscular Centre